Angioscopic Evaluation of Atrial Septal Defect Closure Device Neo‐Endothelialization

Angioscopic Evaluation of Atrial Septal Defect Closure Device Neo‐Endothelialization

Background Current guidelines recommend at least 6 months of antithrombotic therapy and antibiotic prophylaxis after septal‐occluding device deployment in transcatheter closure of atrial septal defect. It has been estimated that it takes ≈6 months for complete neo‐endothelialization; however, neo‐en...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yasuhiro Tanabe, Tomomi Suzuki, Shingo Kuwata, Masaki Izumo, Hiromasa Kawaguchi, Shun Ogoda, Nozomi Kotoku, Yukio Sato, Haruka Nishikawa, Toshiki Kaihara, Masashi Koga, Takanobu Mitarai, Kazuaki Okuyama, Ryo Kamijima, Yuki Ishibashi, Kihei Yoneyama, Takumi Higuma, Tomoo Harada, Yoshihiro J. Akashi
Formato: article
Lenguaje:EN
Publicado: Wiley 2021
Materias:
angioscopy
atrial septal defect
device neo‐endothelialization
Diseases of the circulatory (Cardiovascular) system
RC666-701
Acceso en línea:https://doaj.org/article/f70c2f2215d84c93b17bb5c1d3262b15
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/f70c2f2215d84c93b17bb5c1d3262b15

Ejemplares similares